Serotonin receptors, type 4: A new hope?

Current Drug Targets

Volumn 10, Issue 11, 2009, Pages 1085-1095

  Lucas, Guillaume ^a  

^a CENTRE DE RECHERCHE FERNAND SEGUIN   (Canada)

Author keywords

5 HT neurons; 5 HT4 receptors; Depression; Dorsal raph nucleus; Fast acting antidepressants; Modulation of mood

Indexed keywords

1 (4 AMINO 5 CHLORO 2 METHOXYPHENYL) 3 (1 BUTYL 4 PIPERIDINYL) 1 PROPANONE; ANTIDEPRESSANT AGENT; AUTORECEPTOR; BENZAMIDE DERIVATIVE; CITALOPRAM; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; FLUOXETINE; FLUVOXAMINE; PRUCALOPRIDE; RECEPTOR SUBTYPE; SEROTONIN 1A RECEPTOR; SEROTONIN 4 AGONIST; SEROTONIN 4 RECEPTOR; SEROTONIN UPTAKE INHIBITOR;

AFTERHYPERPOLARIZATION; ALTERNATIVE RNA SPLICING; BASAL GANGLION; BEHAVIOR; BRAIN FUNCTION; DEPRESSION; DOPAMINE RELEASE; DRUG MECHANISM; DRUG POTENCY; DRUG POTENTIATION; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; ELECTROPHYSIOLOGY; FACILITATION; GENE EXPRESSION; HIPPOCAMPUS; HUMAN; MESOLIMBIC DOPAMINERGIC SYSTEM; NEUROPHYSIOLOGY; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; POSTSYNAPTIC POTENTIAL; PREFRONTAL CORTEX; PRESYNAPTIC NERVE; PROTEIN STRUCTURE; PROTEIN VARIANT; PYRAMIDAL NERVE CELL; RECEPTOR DOWN REGULATION; REVIEW; SEROTONIN UPTAKE; TISSUE DISTRIBUTION; ANIMAL; DRUG DEVELOPMENT; GENETICS; MOLECULAR CLONING; PHYSIOLOGY;

ANIMALS; ANTIDEPRESSIVE AGENTS; CLONING, MOLECULAR; DRUG DISCOVERY; HUMANS; RECEPTORS, SEROTONIN, 5-HT4; SEROTONIN 5-HT4 RECEPTOR AGONISTS;

EID: 70450173564     PISSN: 13894501     EISSN: None     Source Type: Journal    
DOI: 10.2174/138945009789735200     Document Type: Review

References (107)

1. Dumuis A, Bouhelal R, Sebben M, Bockaert, J. A 5-HT receptor in the central nervous system, positively coupled with adenylate cyclase, is antagonized by ICS 205 930. Eur J Pharmacol1988; 146: 187-188
2. Dumuis A, Bouhelal R, Sebben M, Cory R, Bockaert JA. A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system. Mol Pharmacol 1988; 34: 880-887 (Pubitemid 19014410)
3. 4 receptor: a place in the sun. Trends Pharmacol Sci 1992; 13:141-145
4. 4 receptor agonists: similar but not the same. Neurogastroenterol Motil 2008; 20: 99-112.
5. 4 receptors. Curr Drug Targets 2004; 3: 39-51.
6. 4 receptor knock-out mice. J Neurosci 2004; 24:412-419
7. Consolo S, Arnaboldi S, Giorgi S, Russi G, Ladinsky H. 5-HT4 receptor stimulation facilitates acetylcholine release in rat frontal cortex. Neuroreport 1994; 5:1230-1232 (Pubitemid 2093555)
8. 4 receptor subtype involvement in the enhancement of striatal dopamine release induced by serotonin: a microdialysis study in the halothane-anesthetized rat. Neuropharmacology 1995; 34:269-279
9. 4 receptor-mediated modulation of 5-HT release in the rat hippocampus in vivo. Br J Pharmacol 1996; 117: 1475-1480
10. 4 receptors exert positive feedback on serotonergic activity: viral transfections, subacute and chronic treatments with 5-HT4 agonists. Biol Psychiatry 2005; 57:918-925
11. 4) receptor agonists are putative antidepressants with a rapid onset of action. Neuron 2007; 55: 712-725
12. Shenker A, Maayani S, Weinstein H, Green JP (1987) Pharmacological characterization of two 5-hydroxytryptamine receptors coupled to adenylate cyclase in guinea pig hippocampal membranes. Mol Pharmacol 1987; 31: 357-367 (Pubitemid 17069803)
13. Dumuis A, Sebben M, Bockaert J. BRL 24924: a potent agonist at a non-classical 5-HT receptor positively coupled with adenylate cyclase in colliculi neurons. Eur J Pharmacol 1989; 162: 381-384 (Pubitemid 19083640)
14. 4) positively coupled to adenylate cyclase in neurons. Naunyn-Schmiedebergs Arch Pharmacol 1989; 340: 403-410
15. 4) receptors positively coupled to adenylate cyclase in adult guinea pig hippocampal membranes: effect of substituted benzamide derivatives. Mol Pharmacol 1990; 37: 408-411
16. 4 receptor positively coupled to adenylate cyclase in brain. Naunyn-Schmiedebergs Arch Pharmacol 1991; 343: 245-251
17. 4 receptor antagonist of the azabicycloalkyl benzimidazolone class: DAU 6285. Naunyn- Schmiedebergs Arch Pharmacol 1992; 345: 264-269
18. Gale JD, Grossman CJ, Whitehead JW, Oxford AW, Bunce KT, Humphrey PP. GR113808: a novel, selective antagonist with high affinity at the 5-HT4 receptor. Br J Pharmacol 1994: 111: 332-338 (Pubitemid 24148746)
19. Gale JD, Grossman CJ, Darton J Bunce KT, Whitehead JWF, Knight J, et al. GR125487: A selective and high affinity 5-HT4 receptorant agonist. Br J Pharmacol 1994; 113 Suppl: 120.
20. 4 receptors in the isolated guinea pig ileum. Naunyn-Schmiedebergs Arch Pharmacol 1992; 345: 387-393
21. Eglen RM, Bonhaus DW, Johnson LG, Leung E, Clark RD. Pharmacological characterization of two novel and potent 5-HT4 receptor agonists, RS 67333 and RS 67506, in vitro and in vivo. Br J Pharmacol 1995; 115:1387-1392
22. 4 receptor. 1. Design of a new class of agonists and receptor map of the agonist recognition site. J Med Chem 1995; 38: 2326-2330
23. Briejer MR, Bosmans JP, Van Daele P, Jurzak M, Heylen L, Leysen JE, et al. The in vitro pharmacological profile of prucalopride, a novel enterokinetic compound. Eur J Pharmacol 2001; 423: 71-83. (Pubitemid 32595730)
24. Grossman CJ, Kilpatrick GJ, Bunce KT. Development of a radioligand binding assay for 5-HT4 receptors in guinea-pig and rat brain. Br J Pharmacol 1993; 109: 618-624 (Pubitemid 23181036)
25. 4 receptors in the human and guinea-pig brain. Neuroreport 1993; 4: 1239-1242
26. Waeber C, Sebben M, Nieoullon A, Bockaert J. Dumuis A. Regional distribution and ontogeny of 5-HT4 binding sites in rodent brain. Neuropharmacology 1994; 33: 527-541 (Pubitemid 24168725)
27. 4 receptors in brains of three species using two structurally distinct radioligands, 3H.GR113808 and 3H.BIMU-1. Neuropharmacology 1994; 33: 1027-1038
28. Patel S, Roberts J, Moorman J, Reavill, C. Localization of serotonin- 4 receptors in the striatonigral pathway in rat brain. Neuroscience 1995; 69(4): 1159-1167
29. 4 receptors in rat basal ganglia and hippocampus. Eur J Neurosci 1996; 8: 2591-2598
30. Bonaventure P, Hall H, Gommeren W, Cras P, Langlois X, Jurzak M, et al. Mapping of serotonin 5-HT(4) receptor mRNA , lig, binding sites in the post-mortem human brain. Synapse 2000; 36: 35-46.
31. 4 receptor mRNA in rat brain by in situ hybridization histochemistry. Brain Res Mol Brain Res 1996; 43: 356-360
32. Mengod G, Vilaró MT, Raurich A, López-Giménez JF, Cortés R, Palacios JM. 5-HT receptors in mammalian brain: receptor autora diography, in situ hybridization studies of new ligands, newly identified receptors. Histochem J 1996; 28: 747-758
33. Ford AP, Clarke DE. The 5-HT4 receptor Med Res Rev 1993, 13: 633-662.
34. Gerald C, Adham N, Kao HT, Olsen MA, Laz TM, Schechter LE, et al. The 5-HT4 receptor: molecular cloning, pharmacological characterization of two splice variants. EMBO J 1995; 14: 2806-2815
35. Claeysen S, Sebben M, Journot L, Bockaert J, Dumuis A. Cloning, expression, pharmacology of the mouse 5-HT(4L) receptor. FEBS Lett 1996; 398: 19-25. (Pubitemid 26400335)
36. 4S receptors Effect of receptor density on their coupling to adenylyl cyclase. Neuroreport 1997; 8(15): 3189-3196
37. Blondel O, Vandecasteele G, Gastineau M, Leclerc S, Dahmoune Y, Langlois M, et al. Molecular , functional characterization of a 5- HT4 receptor cloned from human atrium. FEBS Lett 1997; 412: 465-474 (Pubitemid 27337091)
38. Blondel O, Gastineau M, Dahmoune Y, Langlois M, Fischmeister R. Cloning expression and pharmacology of four human 5-hydroxytryptamine 4 receptor isoforms produced by alternative splicing in the carboxyl terminus. J Neurochem 1998; 70: 2252-2261 (Pubitemid 28252350)
39. 4 receptors: cloning, expression of new splice variants. Ann N Y Acad Sci 1998; 861: 49-56.
40. Bockaert J, Claeysen S, Sebben M, Dumuis A. 5-HT4 receptors: gene, transduction , effects on olfactory memory. Ann N Y Acad Sci 1998, 861: 1-15. (Pubitemid 29047693)
41. 4 receptor splice variants show marked constitutive activity: role of the C-terminal intracellular domain. Mol Pharmacol 1999; 55: 910-920
42. 4 splice variant. J Neurochem 2000; 74: 478-489
43. Claeysen S, Sebben M, Bécamel C, Parmentier ML, Dumuis A, Bockaert J. Constitutively active mutants of 5-HT4 receptors are they in unique active states? EMBO Rep 2001; 2: 61-67
44. Claeysen S, Sebben M, Bécamel C, Eglen RM, Clark RD, Bockaert J, et al. Pharmacological properties of 5-Hydroxytryptamine(4) receptor antagonists on constitutively active wild-type, mutated receptors. Mol Pharmacol 2000; 58: 136-144
45. Andrade R, Chaput Y. 5-Hydroxytryptamine4-like receptors mediate the slow excitatory response to serotonin in the rat hippocampus. J Pharmacol Exp Ther 1992; 257: 930-937
46. Fagni L, Dumuis A, Sebben M, Bockaert J. The 5-HT4 receptor subtype inhibits K+ current in colliculi neurones via activation of a cyclic AMP-dependent protein kinase. Br J Pharmacol 1992; 1054: 973-979
47. Torres GE, Chaput Y, Andrade R. Cyclic AMP , protein kinase A mediate 5-hydroxytryptamine type 4 receptor regulation of calciumactivated potassium current in adult hippocampal neurons. Mol Pharmacol 1995; 47: 191-197
48. Ansanay H, Dumuis A, Sebben M, Bockaert J, Fagni L. cAMPdependent, long-lasting inhibition of a K+ current in mammalian neurons. Proc Natl Acad Sci USA 1995; 92: 6635-6639
49. 4 receptor activation in the rat hippocampus. Naunyn-Schmiedebergs Arch Pharmacol 1997; 355: 14-19
50. 4 receptor activation induces long-lasting EPSP-spike potentiation in CA1 pyramidal neurons. Eur J Neurosci 2006; 24: 719-731
51. 4 receptor involvement in the enhancement of acetylcholine release by pchloroamphetamine in rat frontal cortex. Brain Res 1997; 772: 95-101.
52. Yamaguchi T, Suzuki M, Yamamoto M. Facilitation of acetylcholine release in rat frontal cortex by indeloxazine hydrochloride: involvement of endogenous serotonin , 5-HT4 receptors. Naunyn- Schmiedebergs Arch Pharmacol 1997; 356: 712-720 (Pubitemid 27525069)
53. Matsumoto M, Togashi H, Mori K, Ueno K, Ohashi S, Kojima T, et al. Evidence for involvement of central 5-HT(4) receptors in cholinergic function associated with cognitive processes: behavioral, electrophysiological, and neurochemical studies. J Pharmacol Exp Ther 2001; 296: 676-682
54. 4 receptors improve social olfactory memory in the rat. Neuropharmacology 1997; 36: 681-687
55. Fontana DJ, Daniels SE, Wong EH, Clark RD, Eglen RM. The effects of novel, selective 5-hydroxytryptamine (5-HT)4 receptor ligands in rat spatial navigation. Neuropharmacology 1997; 36: 689-696
56. Marchetti-Gauthier E, Roman FS, Dumuis A, Bockaert J, Soumireu- Mourat B. BIMU1 increases associative memory in rats by activating 5-HT4 receptors. Neuropharmacology 1997; 36: 697-706. (Pubitemid 27272116)
57. 4 receptors in the mouse passive avoidance test. J Pharmacol Exp Ther 1998; 286: 1115-1121
58. Marchetti E, Dumuis A, Bockaert J, Soumireu-Mourat B, Roman FS. Differential modulation of the 5-HT(4) receptor agonists , antagonist on rat learning, memory. Neuropharmacology 2000; 39: 2017-2027
59. Lamirault L, Simon H. Enhancement of place and object recognition memory in young adult and old rats by RS 67333, a partial agonist of 5-HT4 receptors. Neuropharmacology 2001; 41: 844-853 (Pubitemid 33001418)
60. Moser PC, Bergis OE, Jegham S, Lochead, A, Duconseille E, Terranova JP, et al. SL650155, a novel 5-hydroxytryptamine(4) receptor partial agonist with potent cognition-enhancing properties. J Pharmacol Exp Ther 2002; 302: 731-741
61. Orsetti M, Dellarole A, Ferri S, Ghi P. Acquisition, retention, , recall of memory after injection of RS67333, a 5-HT(4) receptor agonist, into the nucleus basalis magnocellularis of the rat. Learn Mem 2003; 10: 420-426
62. 4 agonist, enhances memory and hippocampal acetylcholine efflux. Neuropharmacology 2007; 53: 563-573
63. 4 receptor ligands to modulate rat striatal dopamine release in vitro, in vivo. Br J Pharmacol 1996; 117: 55-62.
64. 4 receptors indirectly enhances in vivo dopamine release in the rat striatum. J Neurochem 1997; 68: 195-203.
65. Thorré K, Ebinger G, Michotte Y. 5-HT4 receptor involvement in the serotonin-enhanced dopamine efflux from the substantia nigra of the freely moving rat: a microdialysis study. Brain Res 1998; 796: 117-124 (Pubitemid 28343240)
66. 4 receptors exert a state-dependent facilitatory control in vivo on nigrostriatal, but not mesoaccumbal, dopaminergic function. Eur J Neurosci 2001; 13: 889-898
67. Porras G, Di Matteo V, De Deurwaerdère P, Esposito E, Spampinato U. Central serotonin4 receptors selectively regulate the impulse- dependent exocytosis of dopamine in the rat striatum: in vivo studies with morphine, amphetamine, cocaine. Neuropharmacology 2002; 43: 1099-1109
68. 4 receptor antagonist, attenuates morphinestimulated dopamine release in the rat striatum. Brain Res 1995; 692: 265-268
69. De Deurwaerdère P, Cervo L, Stinus L, Spampinato U. Central 5- HT(4) receptors and dopamine-dependent motor behaviors: searching for a functional role. Pharmacol Biochem Behav 2002; 71: 627-633
70. Barnes, NM, Cheng, CH, Costall, B, Ge, J, Naylor, RJ. Differential modulation of extracellular levels of 5-hydroxytryptamine in the rat frontal cortex by (R)- , (S)-zacopride. Br J Pharmacol 107: 233-239
71. Blier P, de Montigny C. Current advances and trends in the treatment of depression. Trends Pharmacol Sci 1994; 15: 220-226 (Pubitemid 24210726)
72. Blier P, de Montigny C. Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders. Neuropsychopharmacology 1999; 21 Suppl 2: 91-98
73. Michelsen KA, Schmitz C, Steinbusch HW. The dorsal raphe nucleus-from silver stainings to a role in depression. Brain Res Rev 2007; 55: 329-342 (Pubitemid 47554453)
74. Haddjeri N, Blier P, de Montigny C. Long-term antidepressant treatments result in a tonic activation of forebrain 5-HT1A receptors. J Neurosci 1998; 18: 10150-10156 (Pubitemid 28543788)
75. Besson A, Haddjeri N, Blier P, de Montigny C. Effects of the coadministration of mirtazapine and paroxetine on serotonergic neurotransmission in the rat brain. Eur Neuropsychopharmacol 2000; 10: 177-188 (Pubitemid 30227618)
76. Blier P, Ward NM. Is there a role for 5-HT1A agonists in the treatment of depression? Biol Psychiatry 2003; 53: 193-203.
77. Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003; 301: 805-809 (Pubitemid 36962615)
78. Artigas F, Nutt DJ, Shelton R. Mechanism of action of antidepressants. Psychopharmacol Bull 2002; 36: 123-132
79. 4 receptors exert a frequency-related facilitatory control on dorsal raphé nucleus 5-HT neuronal activity. Eur J Neurosci 2002; 16: 817-822
80. Conductier G, Dusticier N, Lucas G, Côté F, Debonnel G, Daszuta A, et al. Adaptive changes in serotonin neurons of the raphe nuclei in 5-HT(4) receptor knock-out mouse. Eur J Neurosci 2006; 24: 1053-1062
81. Evrard A, Malagié I, Laporte AM, Boni C, Hanoun N, Trillat AC, et al. Altered regulation of the 5-HT system in the brain of MAO-A knock-out mice. Eur J Neurosci 2002; 15: 841-851 (Pubitemid 35463648)
82. Nibuya M, Nestler EJ, Duman RS. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci 1996; 16: 2365-2372 (Pubitemid 26154346)
83. Thome J, Sakai N, Shin K, Steffen C, Zhang YJ, Impey S, et al. cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment. J Neurosci 2000; 20: 4030-4036 (Pubitemid 30365673)
84. Tiraboschi E, Tardito D, Kasahara J, Moraschi S, Pruneri P, Gennarelli M, et al. Selective phosphorylation of nuclear CREB by fluoxetine is linked to activation of CaM kinase IV and MAP kinase cascades. Neuropsychopharmacology 2004; 29: 1831-1840 (Pubitemid 39336795)
85. Castrén E. Neurotrophic effects of antidepressant drugs. Curr Opin Pharmacol 2004; 4: 58-64.
86. Malberg JE, Eisch AJ, Nestler EJ, Duman RS. (2000) Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 2000; 20: 9104-9110 (Pubitemid 32042912)
87. Duman RS, Nakagawa S, Malberg J. Regulation of adult neurogenesis by antidepressant treatment. Neuropsychopharmacology 2001; 25: 836-844 (Pubitemid 34031890)
88. Nestler EJ, Barrot M, Di Leone RJ, Eisch AJ, Gold SJ, Monteggia LM. Neurobiology of depression. Neuron 2002; 34: 13-25.
89. Ohtsuki T, Ishiguro H, Detera-Wadleigh SD, Toyota T, Shimizu H, Yamada K, et al. Association between serotonin 4 receptor gene polymorphisms and bipolar disorder in Japanese case-control samples, the NIMH genetics initiative bipolar pedigrees. Mol Psychiatry 2002; 7: 954-961 (Pubitemid 35333050)
90. 3 and cAMP in brains from depressed violent suicide victims. Neuropsychobiology 2004; 49: 189-195
91. 4 receptor agonist as a faster acting antidepressant. Soc Neurosci Abs 2008; 34: 56-65
92. 1B receptor function by p11 in depression-like states. Science 2006; 311: 77-80.
93. 4 receptors to produce antidepressant responses. Soc Neurosci Abs 2008; 34: 56-58
94. Greene J, Banasr M, Duman RS. Antidepressant treatment increases vegf expression in the hippocampus: role of specific 5-HT receptor subtypes and behavioral consequences. Soc Neurosci Abs 2008; 34: 56-113
95. Warner-Schmidt JL, Duman RS. VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants. Proc Natl Acad Sci USA 2007; 104: 4647-4652
96. Celada P, Puig MV, Casanovas JM, Guillazo G, Artigas F. Control of dorsal raphe serotonergic neurons by the medial prefrontal cortex: Involvement of serotonin-1A, GABA(A) and glutamate receptors. J Neurosci 2001; 21: 9917-9929 (Pubitemid 34184076)
97. Martín-Ruiz R, Ugedo L. Electrophysiological evidence for postsynaptic 5-HT(1A) receptor control of dorsal raphe 5-HT neurons. Neuropharmacology 2001; 41: 72-78 (Pubitemid 32607646)
98. Feng J, Cai X, Zhao JH, Yan Z. Serotonin receptors modulate GABA(A) receptor channels through activation of anchored protein kinase C in prefrontal cortical neurons. J Neurosci 2001; 21: 6502-6511 (Pubitemid 32781094)
99. Cai X, Flores-Hernandez J, Feng J, Yan Z. Activity-dependent bidirectional regulation of GABA(A) receptor channels by the 5- HT(4) receptor-mediated signalling in rat prefrontal cortical pyramidal neurons. J Physiol 2002; 540: 743-759
100. Soubrié P, Reisine TD, Glowinski J. Functional aspects of serotonin transmission in the basal ganglia: a review , an in vivo approach using the push-pull cannula technique. Neuroscience 1984; 13: 605-625
101. Soubrié P. Serotonergic neurons and behavior. J Pharmacol 1986; 17:107-112
102. Spoont MR. Modulatory role of serotonin in neural information processing: implications for human psychopathology. Psychol Bull 1992; 112: 330-350
103. 4 receptors is mediated by increases in CART in the nucleus accumbens. Proc Natl Acad Sci USA 2007; 104: 16335-16340
104. Lucas JJ, Yamamoto A, Scearce-Levie K, Saudou F, Hen R. Absence of fenfluramine-induced anorexia and reduced c-Fos induction in the hypothalamus, central amygdaloid complex of serotonin 1B receptor knock-out mice. J Neurosci 1998; 18: 5537-5544 (Pubitemid 28311968)
105. Vickers SP, Clifton PG, Dourish CT, Tecott LH. Reduced satiating effect of d-fenfluramine in serotonin 5-HT(2C) receptor mutant mice. Psychopharmacology 1999; 143: 309-314
106. Duman RS. A silver bullet for the treatment of depression? Neuron 2007; 55: 679-681
107. Ansanay H, Sebben M, Bockaert J, Dumuis A. Characterization of homologous 5-hydroxytryptamine4 receptor desensitization in colliculi neurons. Mol Pharmacol 1992; 42: 808-816 (Pubitemid 23021484)